6 research outputs found
Systematic review and meta-analysis of response rates and diagnostic yield of screening for type 2 diabetes and those at high risk of diabetes
Background Screening for type 2 diabetes (T2DM) and individuals at risk of diabetes has
been advocated, yet information on the response rate and diagnostic yield of different
screening strategies are lacking.
Methods Studies (from 1998 to March/2015) were identified through Medline, Embase and
the Cochrane library and included if they used oral glucose tolerance test (OGTT) and WHO-
1998 diagnostic criteria for screening in a community setting. Studies were one-step strategy
if participants were invited directly for OGTT and two, three/four step if participants were
screened at one or more levels prior to invitation to OGTT. The response rate and diagnostic
yield were pooled using Bayesian random-effect meta-analyses.
Findings 47 studies (422754 participants); 29 one-step, 11 two-step and seven three/four-step
were identified. Pooled response rate (95% Credible Interval) for invitation to OGTT was
65.5% (53.7, 75.6), 63.1% (44·0, 76.8), and 85.4% (76.4, 93.3) in one, two and three/fourstep
studies respectively. T2DM yield was 6.6% (5.3, 7.8), 13.1% (4.3, 30.9) and 27.9% (8.6,
66.3) for one, two and three/four-step strategies respectively. The number needed to invite to
the OGTT to detect one case of T2DM was 15, 7.6 and 3.6 in one, two, and three/four-step
strategies. In two step strategies, there was no difference between the response or yield rates
whether the first step was blood test or risk-score. There was evidence of substantial
heterogeneity in rates across study populations but this was not explained by the method of
invitation, study location (rural versus urban) and developmental index of the country in
which the study was performed. Conclusions Irrespective of the invitation method, developmental status of the countries and
or rural/urban location, using a multi-step strategy increases the initial response rate to the
invitation to screening for diabetes and reduces the number needed to have the final
diagnostic test (OGTT in this study) for a definite diagnosis